Navigation Links
ProMetic provides business update - Over $35 million worth of business secured in January
Date:2/6/2008

- Shipment of prion capture resin to MacoPharma in Q1 2008; - MacoPharma increased its forecast for P-Capt(R) filters sale in 2008; - Use of affinity prion adsorbent for plasma-derived products to generate

in excess of $25 M over the next 5 years

- $4 M in 2008; - 10th product approved by the FDA and or the EMEA, contributing to revenue

growth.

MONTREAL, Feb. 6 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today provided an update on its business activities.

"Key milestones were achieved in January, a prelude to the announced growth for 2008 and beyond," stated Pierre Laurin, ProMetic's President and Chief Executive Officer. "With our Protein Technologies Business expected to be EBITDA positive this year, and to generate an EBITDA in excess of $15 M in 2009, as well as a partnering of PBI-1402 in 2008, we clearly are on track to deliver value to our shareholders," added Mr. Laurin.

- ProMetic to ship prion capture resin in Q1 2008 for incorporation into

the P-Capt(R) filter. This is in response to MacoPharma's increased

product requirements to meet the expected sales of the P-Capt(R) filter

to Ireland and the UK in 2008. This favorably impacts ProMetic revenue

as of the first half of 2008.

- ProMetic confirmed the decision of a major European plasma fractionator

to scale-up the prion removal process. This process ensures the removal

of any abnormal prion proteins that may be present in donated plasma

and will add another level of safety to the already established

treatment protocols.

- Expected completion of the scale-up phase is June 2008, providing

ProMetic approximately $1 M;

- Including Kedrion, this will signify two major European plasma

fractionators using the prion reduction resin at scal
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
2. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
3. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
4. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
5. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
6. YM BioSciences provides update on AeroLEF(TM) clinical development program
7. ViroPharma Provides 2008 Outlook
8. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
9. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
10. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
11. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 03, 2015 , ... Cuvettes have been used in countless labs for decades. In ... cuvette they needed. As expected, this was a daunting and tiring process looking at ... they were not able to navigate the complex catalog structure. , Now thanks to FireflySci, ...
(Date:7/2/2015)... ... July 02, 2015 , ... Sleepless nights will become obsolete as ... sleep, launched its Indiegogo campaign on June 23. Sound sleepers and the sleep deprived ... it effortless to use, while the integration of the Bluetooth speaker, alarm clock and ...
(Date:7/1/2015)... Mass. , July 1, 2015   ... most frequently cited advantages of Otezla are its ... safety profile, as reported by surveyed rheumatologists. Otezla ... launched for the treatment of active psoriatic arthritis ... The current standard of care includes conventional oral ...
(Date:7/1/2015)... , July 1, 2015  Axovant Sciences ... focused on the treatment of dementia, today announced ... on July 22 at 5:45 p.m. EDT following ... Alzheimer,s Association International Conference 2015 (AAIC). ... , Dr. Lawrence Friedhoff , ...
Breaking Biology Technology:New Cuvette E-Commerce Website Launched by FireflySci 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
... Twenty-two Brazilian companies and entities linked to biotechnology are taking ... 3 to 6 , in Chicago ( USA ), ... Brazil ). At the Convention the BrBiotec Brazil brand will be ... Brazil will have a large stand and will hold many ...
... , May 5 The untimely death of Michael ... forefront of American media recently. The good news for people suffering with ... , , , ... is called radiofrequency thermocoagulation therapy. Used to treat pain caused from a ...
... May 5 /PRNewswire/ - DNA Genotek, a leading ... preparation, today announced that The Anthony Nolan Trust, the ... DNA for a pilot project aimed at increasing donor ... registries, use HLA DNA testing to match leukemia patients ...
Cached Biology Technology:Brazilian Biotechnology Present at BIO 2010 Is Looking for the Worldwide Market 2Medication Doesn't Have to be the Answer to Pain; Southeast Pain Care Offers Pill-free Pain Relief 2DNA Genotek's Oragene(R) DNA Product Selected by The Anthony Nolan Trust for Pilot Project 2DNA Genotek's Oragene(R) DNA Product Selected by The Anthony Nolan Trust for Pilot Project 3DNA Genotek's Oragene(R) DNA Product Selected by The Anthony Nolan Trust for Pilot Project 4
(Date:6/16/2015)... GOTHENBURG, Sweden , June 16, 2015 ... 2015 from previously communicated that it will amount to at ... 390 MSEK. Due to the rapid increase in market growth ... from the previously communicated guidance that revenue for 2015 will ... 2015 will amount to approximately 2,200 MSEK. Due ...
(Date:6/15/2015)... June 15, 2015 A new report ... reveals the majority of US consumers using mobile banking applications ... such as fingerprint and voiceprint, instead of having to prove ... to Telstra,s " Mobile Identity   -   The Fusion ... with smartphones now the primary channel used by Gen X ...
(Date:6/12/2015)... , June 12, 2015  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... its patent to electronically capture, analyze and identify ... facial recognition methods. This system can: ... by an enrollment and subsequent sign-on process is ...
Breaking Biology News(10 mins):Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2
... GNS Healthcare, Inc. (GNS) is collaborating with ... research with a supercomputing platform that can rapidly uncover ... imaging, genetics, pathology, and other areas. The results could ... treatment. GNS will analyze NCI data from ...
... psychiatric illness such as depression or anxiety before a ... are strongly predictive of post-TBI psychiatric disorders, according to ... a peer-reviewed journal published by Mary Ann Liebert, Inc. ... In addition to a pre-injury psychiatric disorder, ...
... 2001--Eating nuts every day could help control Type 2 ... from St. Michael,s Hospital and the University of Toronto. ... Diabetes Care , a team of researchers led ... Nutritional Sciences; St. Michael,s Hospital Risk Factor Modification Centre) ...
Cached Biology News:GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients 2GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients 3A 'nutty' solution to type 2 diabetes management 2
... 2 mM sodium phosphate buffer, pH 6.5. ... is a major lysosomal aspartyl protease in ... proenzyme. Overexpression of cathepsin D in human ... of relapse and metastasis. Cathepsin D degrades ...
... Grade Thrombin is a highly purified preparation ... with appropriate vectors. The preparation is functionally ... is free of detectable contaminating proteases. Prepared ... by certified tests to be negative for ...
Rat Hepatocytes (RH) (>3,000,000 cells)...
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
Biology Products: